Macy W. Gilmour

Macy W. Gilmour

Auto-generated profile, based on publicly available information

Macy W. Gilmour

University of Washington 3 Department of Dermatology Seattle, Washington

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2026
Verified
Other
Open access
HCHaroldo J. Rodriguez Chevez
Haroldo J. Rodriguez Chevez
ARAllison J. Remington
Allison J. Remington
MGMatthew D. Gray
Matthew D. Gray
RARian Alam
Rian Alam
MGMacy W. Gilmour
Macy W. Gilmour
JTJustin J. Taylor
Justin J. Taylor
Additional analyses of CD4+ T cells in MCC tumors.

18 June 2026
Verified
Other
Open access
PDF file
HCHaroldo J. Rodriguez Chevez
Haroldo J. Rodriguez Chevez
ARAllison J. Remington
Allison J. Remington
MGMatthew D. Gray
Matthew D. Gray
RARian Alam
Rian Alam
MGMacy W. Gilmour
Macy W. Gilmour
JTJustin J. Taylor
Justin J. Taylor
The frequency of T-Ag-specific B cells in the blood does not associate with levels of T-Ag-specific antibodies in the blood or outcome.

18 June 2026
Verified
Other
Open access
HCHaroldo J. Rodriguez Chevez
Haroldo J. Rodriguez Chevez
ARAllison J. Remington
Allison J. Remington
MGMatthew D. Gray
Matthew D. Gray
RARian Alam
Rian Alam
MGMacy W. Gilmour
Macy W. Gilmour
JTJustin J. Taylor
Justin J. Taylor
Multiplex immunohistochemistry staining of MCC tumor microarrays.

4 March 2026 in Cancer Immunology Research
Verified
Journal Article
Closed access
PDF file
HCHaroldo J. Rodriguez Chevez
Haroldo J. Rodriguez Chevez
ARAllison J. Remington
Allison J. Remington
MGMatthew D. Gray
Matthew D. Gray
RARian Alam
Rian Alam
MGMacy W. Gilmour
Macy W. Gilmour
JTJustin J. Taylor
Justin J. Taylor
Merkel cell carcinomas (MCC) typically arise from the clonal integration of the Merkel cell polyomavirus. Immunogenic viral oncoproteins then lead to tumorigenesis. Oncoprotein-specific T cells are essential for anti-MCC immunity, but it is unclear whether B cells promote tumor control. In this study, we analyzed the frequency and phenotype of viral oncoprotein–specific and total B cells in blood samples from 47 patients with MCC and tumor samples from another 19 patients with MCC. The phenotype of blood B cells did not correlate with the outcomes of patients with MCC. In contrast, all 11 patients with robust oncoprotein-specific antibody-secreting and/or germinal center B cells in tumors experienced long-term MCC control. In vitro, B cells engineered to be specific for viral oncoproteins increased the sensitivity of oncoprotein-specific CD4+ T cells by more than 50-fold. Together, our findings suggest that cancer-specific B cells promote antitumor immunity via increased responses by T cells and that cancer-specific augmentation of B cells could be therapeutically relevant. See related Spotlight, p. 716

18 June 2026
Verified
Other
Open access
PDF file
HCHaroldo J. Rodriguez Chevez
Haroldo J. Rodriguez Chevez
ARAllison J. Remington
Allison J. Remington
MGMatthew D. Gray
Matthew D. Gray
RARian Alam
Rian Alam
MGMacy W. Gilmour
Macy W. Gilmour
JTJustin J. Taylor
Justin J. Taylor
Overall Frequency of T cells, B cells, and MCC cells in tumor samples does not associate with MCC progression after treatment.

18 June 2026
Verified
Other
Open access
HCHaroldo J. Rodriguez Chevez
Haroldo J. Rodriguez Chevez
ARAllison J. Remington
Allison J. Remington
MGMatthew D. Gray
Matthew D. Gray
RARian Alam
Rian Alam
MGMacy W. Gilmour
Macy W. Gilmour
JTJustin J. Taylor
Justin J. Taylor
Higher frequency of antigen-experienced B cells in blood of female patients near diagnosis associates with MCC progression.